We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Bayer HealthCare

Bayer's radiology division provides diagnostic imaging solutions, which includes medical devices, contrast media, int... read more Featured Products: More products

Download Mobile App




Nuclear Medicine Market Exhibits Slow Growth

By MedImaging International staff writers
Posted on 20 Jun 2016
Print article
The slow growth of the global nuclear medicine market is driven by lower revenues from technetium-99m-related products and unfavorable USD exchange rates against major currencies. These are the latest findings of Medraysintell (Louvain-la-Neuve, Belgium), a provider of strategic intelligence for radiation healthcare.

According to the Medraysintell 2016 Nuclear Medicine World Market Report & Directory, the global market for nuclear medicine radiopharmaceuticals reached USD 4.3 billion in 2015, growing by just over 2% a year between 2013 and 2015. The slow growth is compensated by the rise in radiotherapeutics, which have grown by about 60% a year from 2013 to 2015, mostly driven by one product, Xofigo (Radium-223), an isotope of radium with an 11.4-day half-life manufactured by Bayer (Leverkusen, Germany).

While the global nuclear medicine market is currently stale, Medraysintell expects it to climb to USD 25 billion by 2030, based on several factors that indicate an increasing demand for nuclear medicine procedures. These include a wider use of nuclear medicine around the world in applications that diverge from traditional ncology and cardiology, and the introduction of new radiopharmaceuticals. The molybdenum-99 shortage issue, which is expected to be solved within the next two years with domestic U.S. reactors coming online, will also influence additional growth.

MEDraysintell also estimates that the nuclear medicine market would have reached over USD 4.7 billion in 2015, if it were not for influence of the negative exchange rate. When discounting this effect, the market would have exhibited an annual growth of more than 7% for the period 2013-2015. The 990–page report and directory describes and analyzes over 360 radiopharmaceuticals and radionuclides and more than 160 companies and institutions active in nuclear medicine.

Related Links:
Medraysintell
Bayer
Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Brachytherapy Planning System
Oncentra Brachy
New
Oncology Information System
RayCare
New
C-Arm with FPD
Digiscan V20 / V30

Print article

Channels

Ultrasound

view channel
Image: Structure of the proposed transparent ultrasound transducer and its optical transmittance (Photo courtesy of POSTECH)

Ultrasensitive Broadband Transparent Ultrasound Transducer Enhances Medical Diagnosis

The ultrasound-photoacoustic dual-modal imaging system combines molecular imaging contrast with ultrasound imaging. It can display molecular and structural details inside the body in real time without... Read more

Nuclear Medicine

view channel
Image: PET/CT of a 60-year-old male patient with clinical suspicion of lung cancer (Photo courtesy of EJNMMI Physics)

Early 30-Minute Dynamic FDG-PET Acquisition Could Halve Lung Scan Times

F-18 FDG-PET scans are a way to look inside the body using a special dye, and these scans can be either static or dynamic. Static scans happen 60 minutes after the dye is administered into the body, showing... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.